Human Urinary Kallidinogenase
Sponsors
XuanwuH 2, Beijing Tsinghua Chang Gung Hospital, Changzhou Qianhong Bio-pharma Co., Ltd., General Hospital of Shenyang Military Region, China-Japan Union Hospital
Conditions
Acute Ischemic StrokeCerebral InfarctionFunctional OutcomesIschemic Stroke
Phase 1
Phase 2
Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase
CompletedNCT02259738
Start: 2013-01-31End: 2014-06-30Updated: 2014-10-08
Tenecteplase Plus Urinary Kallidinogenase for Acute Ischemic Stroke (TUKIS)
RecruitingNCT07283159
Start: 2026-01-20End: 2027-12-30Target: 200Updated: 2026-01-23
Unknown Phase
Effects of Human Urinary Kallidinogenase on Early Improvement and Functional Outcomes in Acute Ischemic Stroke (TK-SPEED)
Not yet recruitingNCT06132880
Start: 2023-12-14End: 2026-12-31Target: 540Updated: 2023-12-06
Efficacy and Safety of Human Urinary Kallidinogenase Combined With Reteplase Intravenous Thrombolysis in the Treatment of Acute Ischemic Stroke
Not yet recruitingNCT07483281
Start: 2026-05-01End: 2028-06-18Target: 220Updated: 2026-03-30